Outlook Therapeutics Price Chart
Outlook Therapeutics Volume Chart
Outlook Therapeutics Market Segments
Regular Trading Hours
*No Trades in Segment
Premarket
-0.0144(-3.31%)
| Open | $0.4353 |
|---|---|
| Close | $0.4209 |
| Low | $0.4209 |
| Low Change | -0.0144 (-3.31%) |
| High | $0.4354 |
| High Change | +0.0001 (+0.02%) |
| Range | $0.0145 |
| Volume | 7.188K |
| Dollar Volume | $3.03K |
After Hours Yesterday
+0.0157(+3.81%)
| Open | $0.4126 |
|---|---|
| Close | $0.4283 |
| Low | $0.4123 |
| Low Change | -0.0003 (-0.07%) |
| High | $0.4394 |
| High Change | +0.0268 (+6.50%) |
| Range | $0.0271 |
| Volume | 8.823K |
| Dollar Volume | $3.78K |
Regular Trading Hours Yesterday
+0.0012(+0.29%)
| Open | $0.4200 |
|---|---|
| Close | $0.4212 |
| Low | $0.4100 |
| Low Change | -0.0100 (-2.38%) |
| High | $0.4333 |
| High Change | +0.0133 (+3.17%) |
| Range | $0.0233 |
| Volume | 788.58K |
| Dollar Volume | $332.15K |
Premarket Yesterday
-0.0089(-2.05%)
| Open | $0.4339 |
|---|---|
| Close | $0.4250 |
| Low | $0.4250 |
| Low Change | -0.0089 (-2.05%) |
| High | $0.4339 |
| High Change | +0.0000 (+0.00%) |
| Range | $0.0089 |
| Volume | 1.621K |
| Dollar Volume | $688.93 |
Outlook Therapeutics Moving Averages
| 5 Day Moving Average (SMA5) | $0.4299 |
|---|---|
| 10 Day Moving Average (SMA10) | $0.4276 |
| 20 Day Moving Average (SMA20) | $0.4296 |
| 50 Day Moving Average (SMA50) | $0.5220 |
| 100 Day Moving Average (SMA100) | $1.1040 |
| 200 Day Moving Average (SMA200) | $1.3961 |
Outlook Therapeutics Statistics
| Average Volume (30 Days) | 1.38M |
|---|---|
| P/E Ratio (Current) | -.35 |
| EPS (Current) | -$1.24 |
| Dividend Yield | 0.00% |
| Free Cash Flow | — |
| Cash Ratio | 0.18 |
| Current Ratio | 0.35 |
| Quick Ratio | 0.28 |
| Debt to Equity | -0.95 |
| Enterprise Value | $63.70M |
| EV to EBITDA | -1.08 |
| EV to Sales | 309.68 |
| Price to Book | -0.93 |
| Price to Cash Flow | — |
| Price to Free Cash Flow | — |
| Price to Sales | 173.64 |
| Return on Assets | -5.64% |
| Return on Equity | 2.67% |
Outlook Therapeutics Stock Splits
There have been 2 stock splits for Outlook Therapeutics (OTLK). The last reverse stock split occured on March 14, 2024 and reduced the outstanding shares at a ratio of 20:1.
| Date | Type | Ratio |
|---|---|---|
| Mar 14, 2024 | Reverse | 20:1 |
| Mar 18, 2019 | Reverse | 8:1 |
Outlook Therapeutics Dividends
There have been no dividends for Outlook Therapeutics (OTLK).